Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'
• EU approves Arrowhead's plozasiran for rare triglyceride disorder